RxDoctor Payments Data

Dina Linfoot, MD

Obstetrics & Gynecology · Savannah, GANPI 1760592927

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $9,625 of the $11,514 with a category attached, or 83.6%. Merck accounts for 61.7% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2019 at $4,693 and has fallen 95.0% since, to $236 in 2025. Among obstetrics & gynecology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,514in general payments, 2019–2025

Across 91 payments — averaging $126.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$7K
  • Organon$3K
  • Astellas Pharma US Inc$287
  • AbbVie$211
  • Sumitomo Pharma America, Inc.$204
  • Hologic Sales And Service, LLC$140
  • plus $788 from 22 others

What the payments were for

  • Speaking & faculty fees$9,62584%
  • Travel & lodging$2142%
  • Food & beverage$1,62114%
  • Education$540%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,514 in reported general payments places this provider in the 95th percentile of 1,324 obstetrics & gynecology providers in Georgia.

See all obstetrics & gynecology providers in Georgia

Medicare billing

Part B allowed, 2024
$6,747
Medicare patients
45
Services billed
71

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
YuvafemEstradiol15$2,335
Estradiol21$1,678
Estradiol (Twice Weekly)Estradiol13$1,558

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Savannah

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →